Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood filtering therapy aimed at soothing immunotherapy side effects

NCT ID NCT06646016

First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 19 times

Summary

This study tested a treatment called extracorporeal photopheresis (ECP) for people with melanoma or lung cancer who developed severe colitis (gut inflammation) from immunotherapy and didn't get better with steroids. ECP involves taking blood, treating white blood cells with a light-activated drug and UV light, then returning them to the body. The goal was to see if ECP could calm the colitis better than standard care. However, the study was withdrawn before enrolling any participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNE-RELATED COLITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, 15213, United States

Conditions

Explore the condition pages connected to this study.